This site is intended for healthcare professionals
News

UK approves phase II/III study evaluating Yeliva in patients hospitalized with severe SARS-CoV-2 infection.- RedHill Biopharma

Read time: 1 mins
Last updated:30th Jun 2020
Published:30th Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com